| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 08/16/2001 | CA2399694A1 A biological molecule based computing method based on a blocking principle |
| 08/16/2001 | CA2399689A1 Gene cluster encoding a nystatin polyketide synthase and its manipulation and utility |
| 08/16/2001 | CA2399623A1 Differentiation of bone marrow cells into neuronal cells and uses therefor |
| 08/16/2001 | CA2399593A1 Antibodies to ccr5 |
| 08/16/2001 | CA2399391A1 Trade molecules and uses related thereto |
| 08/16/2001 | CA2399388A1 Identification of a domain in the tumor necrosis factor receptor family that mediates pre-ligand receptor assembly and function |
| 08/16/2001 | CA2399387A1 Heterologous polypeptide of the tnf family |
| 08/16/2001 | CA2399364A1 Method for detecting and quantifying adenovirus |
| 08/16/2001 | CA2399349A1 Novel elongase gene and method for producing multiple-unsaturated fatty acids |
| 08/16/2001 | CA2399266A1 Improved galactosylation of recombinant glycoproteins |
| 08/16/2001 | CA2399148A1 Antibodies that bind human interleukin-18 and methods of making and using |
| 08/16/2001 | CA2399019A1 Proteins producing an altered immunogenic response and methods of making and using the same |
| 08/16/2001 | CA2398775A1 Inhibitor of hepatocyte growth factor activator for use in modulation of angiogenesis and cardiovascularization |
| 08/16/2001 | CA2398750A1 Nucleozymes with endonuclease activity |
| 08/16/2001 | CA2398571A1 Materials and methods for treating ocular-related disorders |
| 08/16/2001 | CA2398483A1 Human neurexin-like proteins and polynucleotides encoding the same |
| 08/16/2001 | CA2398282A1 Method and reagent for the modulation and diagnosis of cd20 and nogo gene expression |
| 08/16/2001 | CA2398136A1 Immunotherapy using interleukin 13 receptor subunit alpha 2 |
| 08/16/2001 | CA2398094A1 Methods for generating hypermutable microbes |
| 08/16/2001 | CA2397369A1 Interferon-alpha induced genes |
| 08/16/2001 | CA2397254A1 Interferon-alpha induced genes |
| 08/16/2001 | CA2392450A1 Nucleic acids, proteins, and antibodies |
| 08/16/2001 | CA2392070A1 Novel invertase inhibitors and methods of use |
| 08/16/2001 | CA2368681A1 Anti-angiogenic intestinal peptides, zdint5 |
| 08/16/2001 | CA2366522A1 Non-naturally occurring nucleic acid compositions, their use for the preparation of formulations useful for transfecting a nucleic acid into cells and applications |
| 08/15/2001 | CN1308685A Nucleic acid detection method |
| 08/15/2001 | CN1308684A Methods for identifying pathways of drug action |
| 08/15/2001 | CN1308683A Methods for generating highly diverse libraries |
| 08/15/2001 | CN1308681A Disease resistant transgenic plants |
| 08/15/2001 | CN1308680A Genomic sequences upstream of the coding region of the G-CSF gene for protein production and delivery |
| 08/15/2001 | CN1308679A Generation of multiple gene products from chimeric fusion proteins by cleavage with ubiquitous endoproteases |
| 08/15/2001 | CN1308678A Cultivar specificity gene from the rice pathogen i(magnaporthe grisea), and methods of use |
| 08/15/2001 | CN1308677A Human tumour-derived polyptde hormone phosphatonin |
| 08/15/2001 | CN1308676A Antibodies to CD23, derivatives thereof, and their therapeutic uses |
| 08/15/2001 | CN1308675A Immunological reagent specifically interating with the extracellular domain of the human zeta chain |
| 08/15/2001 | CN1308674A Multivalent T cell receptor complexes |
| 08/15/2001 | CN1308673A Modifing the expression of the FSH beta gene by homologous recombination |
| 08/15/2001 | CN1308671A Myelin basic protein peptides and uses thereof |
| 08/15/2001 | CN1308637A Binding molecules derived from immunolobulins which do not trigger complement mediated lysis |
| 08/15/2001 | CN1308543A Oxidized thymosin beta 4 |
| 08/15/2001 | CN1308127A Expression carrier for recombinant human B lymphocyte stimulating factor and its construction process |
| 08/15/2001 | CN1308126A Chitinase gene of china bollworm virus |
| 08/15/2001 | CN1308125A Nucleotide sequence coding pck gene |
| 08/15/2001 | CN1308124A Preparation and application of antibiotic peptide beer yeast |
| 08/15/2001 | CN1308123A Preparation and application of antibiotic peptide pichia yeast |
| 08/15/2001 | CN1069699C Active recombination amidate enzyme and its amidate modification application for polypeptide |
| 08/15/2001 | CA2332132A1 Assays for measurement of type ii collagen fragments in urine |
| 08/14/2001 | US6274796 Herbicide resistant rice |
| 08/14/2001 | US6274792 Plants and processes for obtaining them |
| 08/14/2001 | US6274791 Methods for strawberry transformation using Agrobacterium tumefaciens |
| 08/14/2001 | US6274790 Recombinant nucleic acid molecule comprising promoter sequence; comprises hybridizable transcriptional regulatory region capable of mediating gene expression in epidermal cells of arabidopsis; environmental stress resistance; waxes |
| 08/14/2001 | US6274789 Rice gene resistant to blast disease |
| 08/14/2001 | US6274788 Bicistronic DNA construct comprising X-myc transgene for use in production of transgenic animal model systems for human hepatocellular carcinoma and transgenic animal model systems so produced |
| 08/14/2001 | US6274726 Hyperbaric, hydrostatic pressure reversable partitioning of nucleic acids, biomolecules between adsorbed and solvated phases; electrode array system, electroconductive fluid, and positioned phase; electophoresis and electroosmosis; forensic |
| 08/14/2001 | US6274723 Dendritic nucleic acids exhibiting maximal self-assembly |
| 08/14/2001 | US6274722 Expression of a foamy virus envelope protein |
| 08/14/2001 | US6274721 Toxins active against pests |
| 08/14/2001 | US6274719 Polynucleotides and polypeptides of the glycopeptidase family; human streptococci microbe diseases targets for development of antibiotics; otitis media, conjunctivitis, pneumonia, bacteremia, meningitis, sinusitis, endocarditis |
| 08/14/2001 | US6274712 Muteins; cell division potent stimulators or superagonists; useful angiogenesis, wound healing, treating ischemia, gastric or duodenal ulcer, neural injury |
| 08/14/2001 | US6274711 Proteins and mimetics which function in regulating, controlling physiology, development, and differentiation of mammalian immune cells including hemopoietic type; cytotoxic t lymphocyte activated or associated antigen (ctla) |
| 08/14/2001 | US6274709 By immunocompetent cells of high molecular weight; at residue 70 is methionine or threonine, antigens for monoclonal antibodies; increases cytotoxicity of killer cells |
| 08/14/2001 | US6274708 Mouse interleukin-11 receptor |
| 08/14/2001 | US6274707 Protein sweetener |
| 08/14/2001 | US6274702 Bone stimulating factor |
| 08/14/2001 | US6274613 Cyclic imines as pesticides |
| 08/14/2001 | US6274562 Method of inhibiting the proliferation and causing the differentiation of cells with IGF-1 receptor antisense oligonucleotides |
| 08/14/2001 | US6274560 Incubating diketide with modified polyketide synthase; recovering; genetic engineering |
| 08/14/2001 | US6274556 Administering polypeptide derivative to treat inflammatory bowel disease and to prevent leukocyte infiltration into tissues |
| 08/14/2001 | US6274554 Method for preventing and treating hearing loss using a neurturin protein product |
| 08/14/2001 | US6274380 Cacnglike3 polynucleotides and expression systems |
| 08/14/2001 | US6274379 Plant sorbitol biosynthetic enzymes |
| 08/14/2001 | US6274373 A disk adapted for analytical dna sequencing; having multiple channels extending from the center spiraling out toward the perimeter, going in clockwise and counterclock wise directions, with multiple intersection points |
| 08/14/2001 | US6274371 A filtration process, lysing microorganism and let the lysate sit for at least 1 minute; then passing the lysate through a filter layer of packed diatomaceous earth, collecting the fraction and isolate the plasmid dna from the fractions |
| 08/14/2001 | US6274369 A transformation kit containing vials of competent escherichia coli containing an f' episome genetic material; for increased transformation frequencies in genetic research |
| 08/14/2001 | US6274366 A dna expression construct transformed in yeast cells; treatment of angiogenesis and tissue remodeling |
| 08/14/2001 | US6274365 A carrier compound containing an active recombinant furin enzyme; gene therapy; treatment of cancer |
| 08/14/2001 | US6274362 RGS-containing molecules and uses thereof |
| 08/14/2001 | US6274361 A polynucleotide encoding a polypeptide sequence for a peptidyl-trna hydrolase; diagnosis and therapy for staphylococcal infections; screening antibiotics, vaccines |
| 08/14/2001 | US6274359 Amino acid sequence; for recombinant production of enzyme and production of 1-alpha, 25-dihydroxyvitamin d3; prevention, diagnosis and treatment of osteoporosis |
| 08/14/2001 | US6274354 Methods using cre-lox for production of recombinant adeno-associated viruses |
| 08/14/2001 | US6274353 Contacting sample with primer having 3'-hydroxyl terminus blocked with group that prevents chain extension, thermostable blocking group removing enzyme, thermostable polymerase, and nucleoside-5'-triphosphates; then heating |
| 08/14/2001 | US6274352 Methods for diagnosing and assessing a predisposition to bipolar affective disorder |
| 08/14/2001 | US6274351 Solid support for solid phase amplification and sequencing and method for preparing the same nucleic acid |
| 08/14/2001 | US6274350 Dna sequences which encode enzymes of defined amino acid sequences; for efficient recombinant production |
| 08/14/2001 | US6274348 Methods for the preparation of positively charged proteins |
| 08/14/2001 | US6274347 Contacting antibody producing cells with fusion protein of extracellular portion of human leukocyte adhesion molecule-1 and constant region of human immunoglobulin g1, then isolating antibodies |
| 08/14/2001 | US6274345 Expression vectors encoding Escherichia coli OmpC as a cell surface anchoring motif |
| 08/14/2001 | US6274344 Methods for recombinant microbial production of fusion proteins and BPI-derived peptides |
| 08/14/2001 | US6274342 Nucleotide sequence; diagnosis; antiinflammatory agents; recombinant culture production |
| 08/14/2001 | US6274341 Culturing cell that has been genetically engineered to inducibly express a tumor suppressor gene product to arrest cell proliferation, then recovering desired product from cell |
| 08/14/2001 | US6274340 DNA sequences enhancing promoter activity |
| 08/14/2001 | US6274338 Human c-Maf compositions and methods of use thereof |
| 08/14/2001 | US6274335 Method of treatment using recombinant human tissue plasminogen activator |
| 08/14/2001 | US6274333 Type-2 neurotensin receptor (NT-R2) |
| 08/14/2001 | US6274332 Mutations in the KCNE1 gene encoding human minK which cause arrhythmia susceptibility thereby establishing KCNE1 as an LQT gene |
| 08/14/2001 | US6274331 Using recombinant dna vectors which encode di-alpha or di-beta globin-like polypeptide having linker, transforming cells, screening for production by determining response to carbon monoxide, determining amino acid sequence of linker |
| 08/14/2001 | US6274324 Specific binding reagent comprising a variable domain protein linked to a support or tracer |
| 08/14/2001 | US6274322 Transfection kit; for use as nucleotide sequence tool during genetic engineering |
| 08/14/2001 | US6274321 Detecting preferential nucleotide sequences in sample; obtain pools of nucleic acids, express coded proteins, monitor, isolate and recover nucleic acid which express preferential protein |
| 08/14/2001 | US6274320 Method of sequencing a nucleic acid |